Alternatives to OrderlyMeds

The async, needle-optional value play: oral or injectable semaglutide and tirzepatide from a low starting price, no video visit, ~3 days to a script — listed with its February 2026 FDA warning letter in plain view.

It shows both prices at once and says which is which: $149/mo with no commitment, $79 on a twelve-month plan. Brand-name is listed, but all three pages say coming soon.

Flat compounded pricing with the post-introductory number actually printed: $149 a month for semaglutide and $229 for tirzepatide, the same at every dose, after intro rates of $119 and $199. For planning purposes that flatness is the useful part — a titration step-up does not change the bill, so the number you budget in month one is the number in month six. All 50 states, and consultation, prescription, medication, shipping and support are inside the price. Watch the word "from" on every figure: the site says dosage and titration can move what you pay.

The only program here that bills insurance, and the hardest to fit around a working week: a scheduled 30-minute video visit is the only way in.

The whole price table before you hand over a detail: $175/mo semaglutide with no commitment, flat at every dose. The advertised $146 is $875 prepaid for six months — and nothing renews on its own.

Trellis Vitality is the cheapest genuinely-disclosed option on this page: $150 a month for compounded semaglutide and $199 for tirzepatide, month to month, with every dosage available at the same price and no membership fee, no consult fee and a $0 assessment. Commit for three or six months and those fall to $140/$133 and $189/$179. It names the pharmacy that compounds the medication — Vials Rx, described as a US state-licensed, cGMP-compliant facility — which is the disclosure most of its cheaper competitors skip, and it covers all 50 states with board-certified clinicians reviewing intake. The caveats are about what it doesn't sell and doesn't say. There is no FDA-approved brand option, no oral formulation, and none of its pricing appears on the homepage at all — you have to reach the GLP-1 product page to find a single number, which makes it look more opaque than it actually is. There is also no postpartum, breastfeeding or PCOS content anywhere.

This record changed completely between checks, and mostly for the better. The founding-member framing that dominated it a week ago is gone: read live on 2026-08-26 KERNX simply says "Semaglutide starts at $129/month and Tirzepatide starts at $229/month. Pricing varies by prescribed dose. No membership fee. No required 3 month plan." What has not gone is the cost outside those figures, and KERNX is unusually straight about it — a provider consultation fee applies when treatment is approved, at $25 for a message-based review, $35 for a standard live visit or $60 for a complex live visit. Two more things this record previously had wrong. It does say where it operates: licensed providers in all 50 states, repeated in its banner and its FAQ. And it publishes a real timeline: a free five-minute assessment, provider review typically within 24 hours, pharmacy processing 1–2 business days and transit 2–3, so most first orders arrive within three to five business days of approval. It also says nothing is charged until a provider approves you.

One of the few candidates verified this pass spanning both a cheap compounded entry ($99/mo semaglutide) and a real brand-name Wegovy/Zepbound fallback, billed once per plan rather than monthly — text-only consult, no video visit, but no stated turnaround time.

Dose-scaling pricing from $189/mo (starting dose) up to $389/mo (top tirzepatide dose), confirmed by pulling the site's own production pricing and states data directly — genuinely specific 48-state coverage (all but AL and MS) and no hidden cancellation fee found in its own Refund Policy.